paper 1

Country


US

Category


Biotechnology

Website


http://www.rambaxy.com

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. It is ranked amongst the top ten generic companies worldwide.

Ranbaxy Laboratories Limited incorporated Ranbaxy Research Foundation in 1985 with an implicit mission of giving impetus to research activity and help in reviving India’s great scientific tradition. The Foundation instituted Ranbaxy Research Awards to recognize original outstanding contributions in the fields of Medical and Pharmaceutical Sciences. Every year the Foundation invites nominations for 4 awards – 3 Awards for Rs. 1,00,000/- each in the fields of Medical Sciences in Basic. Applied and Clinical Research and 1 Awards of Rs. 1,00,000/- each in the fields of Medical Sciences in Basic. Applied and Clinical Research and 1 Awards of Rs. 1,00,000/- in the field of Pharmaceutical Sciences. So far 62 scientists have been honoured by the Foundation. Ranbaxy Research Foundation was later reconstituted as a separate society as Ranbaxy Science Foundation and registered under the Societies Act in May 1994.

Late Prof. V. Ramalingaswami, was the founder Chairman of the Ranbaxy Science Foundation a non-profit organization.





















The Indian pharmaceutical industry is at the center stage in the global healthcare arena and Ranbaxy endeavors to be at the forefront in delivering the India centric advantages to the advanced and developing countries of the world.

From a small domestic company at inception, Ranbaxy has grown formidably to be a Billion dollar institution that was envisioned by Late Dr Parvinder Singh, Chairman and Managing Director, Ranbaxy in early 90's.

It is with the unwavering ' dedication ' and the ' will to win ' of Team Ranbaxy across the globe that we have traversed this journey so far. The next league is a greater challenge, as we have another milestone to achieve.

Whilst we continue to enhance the momentum of our generics business in our key geographies, parallel to that we are also accelerating our drug discovery program. We are committed to provide quality generics at affordable prices to the patients worldwide with a view to help bring down the healthcare costs. We are confident that our efforts would see the Company emerge as a leading player in the global generic space in the years to come.

As we move ahead towards our mission to become a Research based International Pharmaceutical Company. We believe it is the spirit of Team Ranbaxy that would enable Ranbaxy to reach out to Vision 2012."